Prot #GA45331: A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy with RO7790121 in Patients with Moderately to Severely Active Crohn’s Disease

Project: Research project

Project Details

StatusActive
Effective start/end date3/21/25 → 12/1/30

Funding

  • ICON Clinical Research, LLC (Prot #GA45331 // Prot #GA45331)
  • Genentech, Inc (Prot #GA45331 // Prot #GA45331)